A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer
Ali Amin Al Olama(University of Cambridge), Zsofia Kote‐Jarai(Institute of Cancer Research), Sonja I. Berndt(National Cancer Institute), David V. Conti(University of Southern California), Fredrick R. Schumacher(University of Southern California), Ying Han(University of Southern California), Sara Benlloch(University of Cambridge), Dennis J. Hazelett(University of Southern California), Zhaoming Wang(National Cancer Institute), Edward J. Saunders(Institute of Cancer Research), Daniel Leongamornlert(Institute of Cancer Research), Sara Lindström, Sara Jugurnauth-Little(Institute of Cancer Research), Tokhir Dadaev(Institute of Cancer Research), Malgorzata Tymrakiewicz(Institute of Cancer Research), Daniel O. Stram(University of Southern California), Kristin A. Rand(University of Southern California), Peggy Wan(University of Southern California), Alex Stram(University of Southern California), Xin Sheng(University of Southern California), Loreall Pooler(University of Southern California), Karen Park(University of Southern California), Lucy Xia(University of Southern California), Jonathan P. Tyrer(University of Cambridge), Laurence N. Kolonel(University of Hawaiʻi at Mānoa), Loı̈c Le Marchand(University of Hawaiʻi at Mānoa), Robert N. Hoover(National Cancer Institute), Mitchell J. Machiela(National Cancer Institute), Merideth Yeager(National Cancer Institute), Laurie Burdette(National Cancer Institute), Charles C. Chung(National Cancer Institute), Amy Hutchinson(National Cancer Institute), Kai Yu(National Cancer Institute), Chee Goh(Institute of Cancer Research), Mahbubl Ahmed(Institute of Cancer Research), Koveela Govindasami(Institute of Cancer Research), Michelle Guy(Institute of Cancer Research), Teuvo L.J. Tammela(Tampere University Hospital), Anssi Auvinen(Tampere University), Tiina Wahlfors(Tampere University), Johanna Schleutker(University of Turku), Tapio Visakorpi(Tampere University Hospital), Katri A. Leinonen(Tampere University Hospital), Jianfeng Xu(Wake Forest University), Markus Aly(Danderyds sjukhus), Jenny Donovan(University of Bristol), Ruth C. Travis(University of Oxford), Timothy J. Key(University of Oxford), Afshan Siddiq(Genomics (United Kingdom)), Federico Canzian(German Cancer Research Center), Kay‐Tee Khaw(University of Cambridge), Atsushi Takahashi(RIKEN Center for Integrative Medical Sciences), Michiaki Kubo(RIKEN Center for Integrative Medical Sciences), Paul D.P. Pharoah(University of Cambridge), Nora Pashayan(University of Cambridge), Maren Weischer(Herlev Hospital), Børge G. Nordestgaard(Herlev Hospital), Sune F. Nielsen(Herlev Hospital), Peter Klarskov(Herlev Hospital), Martin Andreas Røder(Copenhagen University Hospital), Peter Iversen(Copenhagen University Hospital), Stephen N. Thibodeau(Mayo Clinic), Shannon K. McDonnell(Mayo Clinic), Daniel J. Schaid(Mayo Clinic), Janet L. Stanford(Fred Hutch Cancer Center), Suzanne Kolb(Fred Hutch Cancer Center), Sarah K. Holt(Fred Hutch Cancer Center), Beatrice Knudsen(Cedars-Sinai Medical Center), Antonio Hurtado Coll, Susan M. Gapstur(American Cancer Society), W. Ryan Diver(American Cancer Society), Victoria L. Stevens(American Cancer Society), Christiane Maier(University Hospital Ulm), Manuel Luedeke(University Hospital Ulm), Kathleen Herkommer(TUM Klinikum), Antje E. Rinckleb(University Hospital Ulm), Sara S. Strom(The University of Texas MD Anderson Cancer Center), Curtis A. Pettaway(The University of Texas MD Anderson Cancer Center), Edward D. Yeboah(Korle Bu Teaching Hospital), Yao Tettey(Korle Bu Teaching Hospital), Richard Biritwum(Korle Bu Teaching Hospital), Andrew A. Adjei(Korle Bu Teaching Hospital), Evelyn Tay(Korle Bu Teaching Hospital), Ann Truelove(Westat (United States)), Shelley Niwa(Westat (United States)), Anand P. Chokkalingam(Berkeley Public Health Division), Lisa Cannon‐Albright(University of Utah), Cezary Cybulski(International Hereditary Cancer Center), Dominika Wokołorczyk(International Hereditary Cancer Center), Wojciech Kluźniak(International Hereditary Cancer Center), Jong Moon Park(Moffitt Cancer Center), Thomas A. Sellers(Moffitt Cancer Center), Hui‐Yi Lin(Moffitt Cancer Center), William B. Isaacs(Johns Hopkins University), Alan W. Partin(Johns Hopkins University), Hermann Brenner(German Cancer Research Center), Aida Karina Dieffenbach(German Cancer Research Center), Christa Stegmaier(Krebsregister Saarland), Constance Chen, Edward L. Giovannucci(Massachusetts Department of Public Health), Jing Ma(Brigham and Women's Hospital), Meir J. Stampfer(Brigham and Women's Hospital), Kathryn L. Penney(Brigham and Women's Hospital), Lorelei A. Mucci(Brigham and Women's Hospital), Esther M. John(Cancer Prevention Institute of California), Sue A. Ingles(University of Southern California), Rick A. Kittles(University of Illinois Chicago), Adam B. Murphy(Northwestern University), Hardev Pandha(University of Surrey), Agnieszka Michael(University of Surrey), Andrzej Kierzek(University of Surrey), William J. Blot(International Epidemiology Institute), Lisa B. Signorello(Brigham and Women's Hospital), Wei Zheng(Vanderbilt University), Demetrius Albanes(National Cancer Institute), Jarmo Virtamo(Finnish Institute for Health and Welfare), Stephanie J. Weinstein(National Cancer Institute), Barbara Nemesure(Stony Brook University), John D. Carpten(Translational Genomics Research Institute), Cristina Leske(Stony Brook University), Suh-Yuh Wu(Stony Brook University), Anselm Hennis(University of the West Indies), Adam S. Kibel(Brigham and Women's Hospital), Benjamin A. Rybicki(Henry Ford Hospital), Christine Neslund‐Dudas(Henry Ford Hospital), Ann W. Hsing(Cancer Prevention Institute of California), Lisa W. Chu(Cancer Prevention Institute of California), Phyllis J. Goodman(Fred Hutch Cancer Center), Eric A. Klein(Cleveland Clinic), Shusen Zheng(Wake Forest University), Jyotsna Batra(Translational Research Institute), Judith A. Clements(Translational Research Institute), Amanda B. Spurdle(QIMR Berghofer Medical Research Institute), Manuel R. Teixeira(Instituto Português de Oncologia Francisco Gentil), Paula Paulo(Instituto Português de Oncologia Francisco Gentil), Sofia Maia(Instituto Português de Oncologia Francisco Gentil), Chavdar Slavov(Medical University of Sofia), Radka Kaneva(Medical University of Sofia), Vanio Mitev(Medical University of Sofia), John S. Witte(University of California, San Francisco), Graham Casey(University of Southern California), Elizabeth M. Gillanders(National Cancer Institute), Daniella Seminara(National Cancer Institute), Elio Ríboli(Imperial College London), Freddie C. Hamdy(University of Oxford), Gerhard A. Coetzee(University of Southern California), Qiyuan Li(Dana-Farber Cancer Institute), Matthew L. Freedman(Dana-Farber Cancer Institute), David J. Hunter, Kenneth Muir(University of Warwick), Henrik Grönberg(Karolinska Institutet), David E. Neal(Cancer Research UK), Melissa C. Southey(The University of Melbourne), Graham G. Giles(Cancer Council Victoria), Gianluca Severi(Cancer Council Victoria), Michael B. Cook(National Cancer Institute), Hidewaki Nakagawa(RIKEN Center for Integrative Medical Sciences), Fredrik Wiklund(Karolinska Institutet), Peter Kraft(Harvard University), Stephen J. Chanock(National Cancer Institute), Brian E. Henderson(University of Southern California), Douglas F. Easton(University of Cambridge), Rosalind A. Eeles(Royal Marsden NHS Foundation Trust), Christopher A. Haiman(University of Southern California)
Cited by 470Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis